Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the developing and commercializing innovative specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity... 
Sector
Pharmaceuticals
Calendar
02/08Earnings Release
More about the company
Latest news on ALLERGAN, INC.
12/08 ALLERGAN, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
12/07 S&P 500 ANALYST MOVES : Agn
12/07 TEVA’S PHARMACEUTICAL INDUSTRI : TEVA) End-Of-Year Switch Of Generics CEO ..
12/06 CELLCEUTIX : CTIX) Advances Pipeline toward Multi-billion Dollar Opportunities, ..
12/05 ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
12/05 ALLERGAN : FDA clearance for Allergan's refractory glaucoma treatment
12/05 ALLERGAN : Zydus cadila settles patent case
12/03 CADILA HEALTHCARE : Zydus announces settlement of patent litigation
12/03 ALLERGAN, INC. : Pomerantz Law Firm Reminds Shareholders with Losses on their In..
12/02 ALLERGAN PLC (NYSE : AGN) Files An 8-K Regulation FD Disclosure
More news
Sector news : Pharmaceuticals - NEC
04:31pDJASTRAZENECA : FDA Accepts License Application for Durvalumab
02:05pDJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON8.05%301 952
ROCHE HOLDING LTD.-19.97%189 184
PFIZER INC.-3.38%187 755
NOVARTIS AG-20.79%178 671
MERCK & CO., INC.13.82%165 759
More Results